Leveraged & Inverse Channel Big Biopharma Mergers Could Fuel These ETFs in 2019 By Ben HernandezJanuary 10, 2019
Leveraged & Inverse Channel Biotech ETFs Hoping This Post-Election Trend Doesn’t Repeat By Brenton GarenNovember 8, 2018
Leveraged & Inverse Channel After a Rough October, Leveraged Biotech ETF Looks to Bounce Back By Brenton GarenNovember 6, 2018